ICU Medical, Inc.

This committee provides the crucial 'scoring' and technical analysis for all tax legislation. Its work directly influences corporate tax rates, deductions, and credits, thereby impacting ICU Medical's financial performance and investment decisions.

This is a pivotal committee for ICU Medical. It controls taxation (directly impacting profitability), trade policy (affecting supply chains and global sales), and entitlement spending (Medicare/Medicaid reimbursement rates are crucial for healthcare providers, who are ICU Medical's customers).

This committee directly allocates discretionary federal spending. Its subcommittees determine the precise funding for agencies like the FDA, NIH, VA, and DoD, all of which directly impact ICU Medical's regulatory environment, research opportunities, and government customer base.

This committee directly regulates the FDA, which is the primary regulatory body for medical devices like those manufactured by ICU Medical. Its oversight of drug approval, medical device safety, and labor laws has a profound and direct impact on the company's operations and market access.

This committee's oversight of intellectual property and antitrust laws is critical for ICU Medical. Protecting patents for its medical devices is vital, and antitrust decisions could impact mergers and acquisitions within its industry.

ICU Medical's products are essential for healthcare. Funding decisions for the Department of Veterans Affairs directly impact government healthcare contractors and could lead to significant procurement opportunities for ICU Medical's devices within VA hospitals and clinics.